SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
DARA BioSciences, Inc. to Present Results of a Clinical Study for KRN5500 at the "Annual Targeting Pain with Novel Therapeutics" Meeting Sponsored by Cambridge Healthtech Institute